This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
Endovastec respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking "Save", only the cookies you selected will be used. You can with draw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.
Thessaloniki, Greece – The Minos™ Abdominal Aortic Stent-Graft and Delivery System (“Minos™”), which is produced by Shanghai MicroPort Endovascular MedTech Co., Ltd. (“Endovastec™”), was successfully implanted in a patient with abdominal aortic aneurysm (AAA) in Greece recently. Professor Georgios A. Pitoulias from General Hospital of Thessaloniki “G. Gennimatas - Agios Dimitrios” was the first expert in Europe to try this product. The case marked the first implantation of Minos™ Stent Graft System outside of China since the device received CE Mark in September 2019.
The patient with AAA had vascular access stenosis at bilateral iliac arteries. The narrowest part of the vascular access at the left iliac artery measured 4.5mm in diameter. As the diameter of the outer sheath of Minos™ Stent Graft System measures 14F (<5mm), the device stood out as one of the optimal choices for the similar cases.
A main-body stent graft (CM24-100) and the limb stent grafts (CL13-80 and CL13-100) were selected during the procedure. The post-operative angiography showed that the aneurysm was effectively excluded without endoleak, with the stent graft in good shape and smooth blood flow through limbs. The procedure turned out to be a success.
Professor Pitoulias commented that Minos™ Stent Graft System not only inherits the advantages of classic abdominal aortic stent grafts, but also achieves breakthroughs and innovation that are demonstrated in its outer sheath design and low profile. He added that he had the confidence to use Minos™ Stent Graft System in future cases of more complexity.
Endovastec™ granted Professor Pitoulias first certificate of using Minos™, and hope Minos™ Stent Graft System can continue to benefit more patients around the world.
As a new generation of abdominal aortic stent graft system independently developed by Endovasctec™, Minos™ is designed for endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysm with proximal neck length no less than 15mm. Its ultra-low profile delivery system with 14F OD offers a better option for the patients who were previously considered ineligible for an EVAR procedure due to smaller, tortuous, or calcified access vessel arteries. It provides a better solution for patients with complex abdominal aortic anatomies, and especially benefits more patients with vascular access stenosis and tortuosity. Minos™ System features a three-piece design which enables in situ customization, allowing a 25-35mm or 25mm-55mm stent overlap for adjustment during operation. M-bare stent is laser-cut with integrated barbs. The main body was constructed by multi nitinol wire braided struts covered with seamless woven graft, and its iliac limbs are woven by a single wire in a spiraling pattern. The unique design ensures a high flexibility even during the treatment of patients with complex anatomies, reduces the rate of complications including endoleak or device migration and occlusion, thus presents a lower risk of reintervention.